Sun Pharma Advanced Research Company Limited (BOM:532872)

BOM:532872 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	69,065	37,284	48,000	119,521	58,203	80,734
Market Cap Growth	32.42%	-22.32%	-59.84%	105.35%	-27.91%	116.74%
Enterprise Value	74,646	41,441	48,951	116,002	60,088	81,455
Last Close Price	212.45	114.60	148.00	369.95	179.45	296.85
PE Ratio	4.45	2.40	-	-	-	-
PS Ratio	176.41	95.23	66.88	158.21	24.38	58.82
PB Ratio	5.16	2.79	-22.12	95.04	11.35	258.55
P/TBV Ratio	5.45	2.94	-	143.93	11.94	995.49
EV/Sales Ratio	190.67	105.85	68.21	153.55	25.17	59.35
EV/EBITDA Ratio	4.67	2.59	-	-	-	-
EV/EBIT Ratio	4.70	2.61	-	-	-	-
Debt / Equity Ratio	0.42	0.42	-1.24	0.49	0.03	2.54
Debt / EBITDA Ratio	0.35	0.35	-	-	-	-
Net Debt / Equity Ratio	0.42	0.42	-1.23	-0.76	-0.75	2.12
Net Debt / EBITDA Ratio	0.35	0.35	-0.82	0.24	1.80	-0.35
Net Debt / FCF Ratio	-2.12	-2.12	-0.72	0.21	4.58	-0.28
Asset Turnover	0.03	0.03	0.17	0.11	0.43	0.54
Inventory Turnover	-	-	17.60	28.64	26.43	25.15
Quick Ratio	0.02	0.02	0.05	0.81	2.47	0.25
Current Ratio	2.47	2.47	0.07	1.02	2.54	0.42
Return on Equity (ROE)	276.89%	276.89%	-	-121.28%	-81.83%	-
Return on Assets (ROA)	79.22%	79.22%	-49.05%	-38.26%	-25.18%	-48.08%
Return on Capital Employed (ROCE)	112.10%	112.10%	862.30%	-164.70%	-34.30%	-180.50%
Earnings Yield	22.49%	41.66%	-7.14%	-3.24%	-3.82%	-2.52%
FCF Yield	-3.80%	-7.04%	-7.72%	-3.81%	-1.45%	-2.98%
Buyback Yield / Dilution	-0.00%	-0.00%	-	-13.99%	-8.19%	-0.42%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 4, 2026

Data Sources Report a data error